Sources

13 Total Sources

Hanmi Pharm Licenses HM17321 to Genentech in $2.3 Billion Obesity Drug Deal

Left67%

Center33%

PR Newswire14h ago

Hanmi Pharm Licenses Obesity Therapy HM17321 to Genentech for $2.3 Billion

biopharmaapac.com19h ago

South Korea's Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech in $2.3B Deal

Korea Economic Daily1h ago

Hanmi Pharmaceutical signs record $2.3 bn obesity drug licensing deal with Roche's Genentech - KED Global

코리아타임스13h ago

Hanmi Pharm signs $2.3 bil. licensing deal with Roche's Genentech for obesity drug candidate - The Korea Times

Hanmi signs $2.3bn obesity drug deal with Genentech | UA.NEWS

pharmacally.com3h ago

Hanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate HM17321 - Pharmacally

koreajoongangdaily.com14h ago

Hanmi Pharm signs $2.3 billion Genentech deal for obesity drug candidate

app.dealroom.co3h ago

Hanmi licenses obesity candidate HM17321 to Roche's Genentech in deal worth up to $2.3bn | Dealroom.co

조선비즈14h ago

Hanmi licenses muscle-preserving obesity drug to Genentech in $2.3b deal - CHOSUNBIZ

finance.biggo.com14h ago

Hanmi Pharmaceutical Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in Deal Worth Up to $2.3 Billion — BigGo Finance

pharmaphorum14h ago

Roche's Genentech strikes $2.3bn deal for Hanmi obesity drug HM17321 | pharmaphorum

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy - AOL

chemxpert.com19h ago

Hanmi Pharm Signs $2.3 Billion Licensing Deal With Genentech for Obesity Drug Candidate HM17321